Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.

International journal of cardiology - 15 Oct 2016

Bielecka-Dabrowa Agata, Sakowicz Agata, Misztal Małgorzata, von Haehling Stephan, Ahmed Ali, Pietrucha Tadeusz, Rysz Jacek, Banach Maciej

Abstract excerpt

BACKGROUND/OBJECTIVES: To evaluate whether biomarkers reflecting pathophysiological pathways and selected single nucleotide polymorphisms differ between patients (pts) with heart failure (HF). METHODS: 110 pts with were involved, including HF pts with preserved ejection fraction (HFpEF, n=51) with hypertensive origin, HF pts with reduced ejection fraction (HFrEF) with ischemic aetiology (ICM) (n=32) and HFrEF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminobutyrates
Share to Angiotensin Receptor Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biphenyl Compounds

Share to Drug Combinations

Share to Myocardial Ischemia

Share to Natriuretic Peptide, Brain

Share to Stroke Volume

Share to Tetrazoles

Source

Identifiers

PMID: 27448535
DOI: 10.1016/j.ijcard.2016.07.150

Genes

NOS3
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.PMID 27448535Read ↗

Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.Semantic proximity Read ↗

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction.Semantic proximity Read ↗

Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy.Semantic proximity Read ↗

The role of circulating cytokines in heart failure: a bidirectional, two-sample Mendelian randomization studySemantic proximity Read ↗

Patient-level comparison of heart failure patients in clinical phenotype and prognosis from China and Sweden.Semantic proximity Read ↗

Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.Semantic proximity Read ↗

Glutathione Transferase P1 Polymorphism Might Be a Risk Determinant in Heart FailureSemantic proximity Read ↗

CRP genetic variants are associated with mortality and depressive symptoms in chronic heart failure patients.Semantic proximity Read ↗

TGF-beta1 gene polymorphisms in patients with end-stage heart failure.Semantic proximity Read ↗

Functional variants in the promoter region of macrophage migration inhibitory factor rs755622 gene (MIF G173C) among patients with heart failure: Association with echocardiographic indices and disease severity.Semantic proximity Read ↗

Plasma soluble fms-like tyrosine kinase-1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failure.Semantic proximity Read ↗

The methionine 196 arginine polymorphism of the TNF receptor 2 gene (TNFRSF1B) is not associated with worse outcomes in heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.